The frequency of hyperkalemia and its significance in chronic kidney disease. - Wikidata - wikimedia - TriplyDB

The frequency of hyperkalemia and its significance in chronic kidney disease.

The frequency of hyperkalemia and its significance in chronic kidney disease.

http://www.wikidata.org/entity/Q36530203

about

Laboratory markers of ventricular arrhythmia risk in renal failure Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia Updates in hyperkalemia: Outcomes and therapeutic strategies.Remote Usability Testing and Satisfaction with a Mobile Health Medication Inquiry System in CKD Adverse safety events in chronic kidney disease: the frequency of "multiple hits"Elevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patients Patient-reported and actionable safety events in CKD.The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial Advances in treatment of hyperkalemia in chronic kidney disease.Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels--a four-years prospective cohort study in Taiwan Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance Hypertension in Cardiovascular and Kidney Disease.Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission.Noninvasive potassium determination using a mathematically processed ECG: proof of concept for a novel "blood-less, blood test"Improving ascertainment of sudden cardiac death in patients with end stage renal disease.Patient safety issues in CKD: core curriculum 2015.A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care.Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function.Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients.Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.Exploring Problems in Following the Hemodialysis Diet and Their Relation to Energy and Nutrient Intakes: The BalanceWise Study.Urinary Sodium and Potassium Excretion and CKD Progression.Potassium and Its Discontents: New Insight, New Treatments Novel Bloodless Potassium Determination Using a Signal-Processed Single-Lead ECG Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding study Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.

P2860

Q27004652-F8DAEE7F-C2C3-43D1-ADE1-8B66FEA1980B Q28831139-49A770F4-0251-44F7-A6EE-735DF26232EC Q30245585-187961E0-1098-4F84-AD7B-F7531BF69641 Q33444517-B3029955-17C7-401C-9580-76E98C50A78C Q33571370-EDADF9F2-E87C-476E-8AF4-6718AEBF72AD Q33729193-A911122C-3AA8-4564-863E-F32BE314673C Q33814930-AB9035F5-FF7F-48B6-9C37-F22286473600 Q34122611-EC8920A5-D5B5-43B1-88D4-B28B2DB0B21C Q34241836-092BE3EE-6464-41DD-AB64-5CE18E8099A6 Q34372881-DA267CDA-42E0-4B2F-8D0E-55B313CEDAED Q34491934-CDE13941-C344-41A4-B6CF-CDB2AA00C869 Q34680658-4D6195C2-6876-42DF-BAF3-F94BE28A87F9 Q34751971-E1A2B5EF-5ADC-472F-8C7F-57D7E98E6D9B Q34812460-E3D2D4B3-B5DD-4301-8DBF-C3590DE51038 Q35128415-1AFB1A98-04F3-4C8B-86F8-7B96B5AF897A Q35158709-F8EC0A41-CDC1-4A03-B8C0-C2D47692594A Q35176802-6824C81C-2345-46E3-9B1E-DB2659237E83 Q35203404-D78C2B87-3711-4A0C-9A0B-F257488AB064 Q35440355-870052EB-59CD-45A5-810A-891392E77A99 Q35556291-467F3D02-5DCC-4753-BA10-FB76E9E4FA81 Q35692484-4AA0E0B8-EDFE-4230-A536-61FBB275D27E Q35798287-818BAC10-D2C4-447A-B3A3-DEFB6A11F23F Q35921862-D4ACE464-A8A7-4E1A-903C-CF1A8F326EA8 Q36008616-C0708161-35A7-4A59-AC81-02DF17B5A7AB Q36100588-D665A4F8-1BB4-41D7-89D0-64E4FC0B51F9 Q36126918-D6B33945-FECF-4B5C-96D9-F548E6EB1017 Q36292990-1457861E-6578-4BAB-B77A-5520ECA3A05F Q36318268-5EA1C331-8273-4040-9732-639205DFF35A Q36349441-A477475C-0477-4E25-8A2B-7C563D79179D Q36369282-DA0F992E-C3B4-4712-90AA-6C49BE68FC71 Q36390782-BE060022-2D72-4AAC-A637-FD93AC49CB1D Q36432845-4D4A2CD3-6A71-4037-9AE4-D06DB55B36C3 Q36604682-A419CB57-DC6B-431C-9D6F-7DC30FA3BF26 Q36746060-05E11011-C38A-4C32-B14A-7BEAA8F21CCD Q36746113-4D561CD7-9971-4328-8C27-4FD3FC84B29E Q36877800-2A3CB420-8FD2-46C3-817B-D120C42E33B2 Q36896690-36666C79-F0BB-4780-AB99-D8D641155A9F Q37119064-56ED25B5-D0E1-4339-8070-7F0749A05F5E Q37325962-B1FD33B9-476C-4748-8212-890B5E1FEA68 Q37359101-D45D4382-77B7-408E-835B-9462BDC098B7

P2860

The frequency of hyperkalemia and its significance in chronic kidney disease.

http://www.wikidata.org/entity/Q36530203

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

The frequency of hyperkalemia and its significance in chronic kidney disease.

@ast

The frequency of hyperkalemia and its significance in chronic kidney disease.

@en

type

label

The frequency of hyperkalemia and its significance in chronic kidney disease.

@ast

The frequency of hyperkalemia and its significance in chronic kidney disease.

@en

prefLabel

The frequency of hyperkalemia and its significance in chronic kidney disease.

@ast

The frequency of hyperkalemia and its significance in chronic kidney disease.

@en

P1433

Q36530203-C5ADBD3D-7B8D-4DC5-8980-EB0075EDC69A

P1476

Q36530203-528506C4-D3F8-42F0-8F0D-340673D705BE

P2093

Q36530203-0947A5E1-C3B4-4DB8-ACDA-39E3F7082C6B

Q36530203-29574218-96AE-4AE4-BC33-4F5F409C51C5

Q36530203-5C2B3038-E1DB-4440-9DD8-F8E94A095103

Q36530203-64C6A94D-A810-46CD-925B-651B275D3F51

Q36530203-A9BFE03C-1C1F-47BC-9D6E-E19471783200

Q36530203-D3E576D1-96A1-4E77-87F5-68044C39F3D7

Q36530203-EBD4C39E-7339-4F8D-83FA-72CCD8C705F8

P2860

Q36530203-02824F64-598B-442C-B3ED-44C76AB170B2

Q36530203-0FD17C57-83F5-415A-83C1-81F1141FFA44

Q36530203-1BC3B9FA-EF57-4E82-8115-DE4AC904AD98

Q36530203-33378CAA-D4F8-40C6-98D1-F095E59B4DB3

Q36530203-367EAF1E-A16E-4583-ABF2-33E273547941

Q36530203-3BE1FDEE-8FF2-4709-83EB-92161923BB4E

Q36530203-423FAB1F-767F-4E2F-B0BB-E4191FE91C74

Q36530203-4ABD91FB-0943-46F4-8339-57C4E58D5883

Q36530203-4C2CD400-90EB-4DDE-B96C-16BC07855000

Q36530203-5478D7C0-269D-4E1F-BFCA-555F683CE48B

P304

Q36530203-635C41F7-DBE3-45AB-B2EF-0FA6B498F803

P31

Q36530203-A0A397E5-9FA0-4AF7-93A2-5553CB30145A

P356

Q36530203-B7D21CD2-43A0-4676-A575-FDA5E1939FAF

P407

Q36530203-48BA78B8-8B78-4933-BEA9-541BC1540DD9

P433

Q36530203-F00CFCBE-A95A-4018-8ABB-9500304D3277

P478

Q36530203-E94B3B5A-43B3-4031-9F45-B8F4BBEA04AD

P50

Q36530203-42D5C5B0-8BEC-4755-919B-A2A58685584C

P577

Q36530203-A98BD59D-DBCC-4F8E-8F16-A7CCEF4C3808

P698

Q36530203-200A9D5D-2432-4D42-939C-C4FC931F34DB

P932

Q36530203-E4D43015-9328-4FC5-B27A-5A8C022A9B4A

P356

ARCHINTERNMED.2009.132

P1433

JAMA Internal Medicine

P1476

The frequency of hyperkalemia and its significance in chronic kidney disease

@en

P2093

Lisa M Einhorn

http://www.w3.org/2001/XMLSchema#string

Lori D Walker

http://www.w3.org/2001/XMLSchema#string

Matthew R Weir

http://www.w3.org/2001/XMLSchema#string

Maureen F Moen

http://www.w3.org/2001/XMLSchema#string

Min Zhan

http://www.w3.org/2001/XMLSchema#string

Stephen L Seliger

http://www.w3.org/2001/XMLSchema#string

Van Doren Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Hemodynamic responses to converting enzyme inhibition in patients with renal disease

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Prevalence of chronic kidney disease in the United States

Data resources in the Department of Veterans Affairs.

Potassium secretion and the regulation of distal nephron K channels.

Are drugs that block the renin-angiotensin system effective and safe in patients with renal insufficiency?

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

How promptly are inpatients treated for critical laboratory results?

Hyperkalemia in dialysis patients.

P304

1156-1162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2009.132

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey C. Fink

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19546417

http://www.w3.org/2001/XMLSchema#string

P932

3544306

http://www.w3.org/2001/XMLSchema#string